Early phase II trial of human rotavirus vaccine candidate RV3

By Barnes G.L.   Lund J.S.   Mitchell S.V.   De Bruyn L.   Piggford L.   Smith A.L.   Furmedge J.   Masendycz P.J.   Bugg H.C.   Bogdanovic-Sakran N.   Carlin J.B.   Bishop R.F.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2950-2956

Elsevier

Access to resources Recommend Favorite

Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration

By Chuang J.H.   Tsay L.W.   Chen C.   Jefferson T.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1487-1495

Elsevier

Access to resources Recommend Favorite

Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation?

By Jaffar S.   Leach A.   Hall A.J.   Obaro S.   McAdam K.P.W.J.   Smith P.G.   Greenwood B.M.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 633-640

Elsevier

Access to resources Recommend Favorite

Randomized, comparative trial of 20 g vs 40 g Engerix B vaccine in hepatitis B vaccine non-responders

By Goldwater P.N.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 353-356

Elsevier

Access to resources Recommend Favorite

SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups

By Lu S.   Manson K.   Wyand M.   Robinson H.L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 920-923

Elsevier

Access to resources Recommend Favorite